INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 July 2012
|
Total net assets |
£128.7m |
|
NAV per share |
232.0p |
|
Share price |
203.3p |
|
Total value of unquoted investments |
£21.1m |
|
Total number of portfolio companies |
69 |
|
Cash |
6% NAV |
|
Cash committed and reserved to unquoted investments |
(5)% NAV |
|
Portfolio companies with < 1 year of cash |
13.95% NAV |
Top Ten Holdings
|
Company Name |
% NAV |
|
Amgen Gilead Sciences Aptiv Solutions |
6.8 4.7 4.5 |
|
Celgene Alexion |
4.2 4.0 |
|
Insulet Pharmaxis Biogen |
3.4 3.1 2.9 |
|
Teva Ariad |
2.7 2.4 |
|
|
----------- |
|
Total |
38.7 |
|
Geographical Allocation |
% |
|
United States & Canada |
80 |
|
Europe |
8 |
|
Israel Australia |
3 3 |
|
Cash |
6 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% |
|
Quoted |
78 |
|
Unquoted |
16 |
|
Cash |
6 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
21 AUGUST 2012